Tenecteplase Placebo, Metalyse 5 000 units (25 mg) powder for solution for injection clinical trials

Early Reperfusion Therapy with Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion (REVISION) - A double-blind randomized placebo-controlled phase III trial

This study, called REVISION, is looking at a medicine called tenecteplase for sudden vision loss caused by a blocked blood vessel in the eye. It wants to see if this medicine can help people regain their vision. This research is important for finding better ways to treat this condition.